Program Status
Currently Closed – We are no longer accepting or processing applications for new or renewal patients.
The PAN Foundation’s Multiple Myeloma fund is currently closed. As of March 25, 2020, Patient Advocate Foundation, Leukemia and Lymphoma Society, and Cancer Care are accepting applications.
For current information, log in to FundFinder.
Assistance Amount
$7,000 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.
Eligibility Criteria
- The patient must be getting treatment for multiple myeloma.
- The patient must have health insurance that covers his or her qualifying medication or product.
- The patient’s medication or product must be listed on PAN’s list of covered medications.
- The patient’s income must fall at or below 500% of the Federal Poverty Level.
- The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
See the list of medications covered in this program
Diagnosis Codes:
ICD-10: C90.00, C90.01, C90.02, C90.10, C90.11, C90.12
About the Disease:
Multiple myeloma (MM), also known as Kahler's disease, is a type of a cancer that causes plasma cells to accumulate in the bone marrow, crowding out healthy cells. It affects the circulatory system. Subtypes include plasma cell leukemia, an aggressive form of multiple myeloma.
Source: National Institutes of Health
Related Organizations:
